Early-stage cognitive impairment in Parkinson's disease and the influence of dopamine replacement therapy

European Journal of Neurology

Volumn 19, Issue 3, 2012, Pages 510-516

  Miah, I P ^a   Olde Dubbelink, K T ^a   Stoffers, D ^a   Deijen, J B ^b   Berendse, H W ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Cognitive performance; Dopamine; Frontal lobe function; Parkinson's disease; Temporal lobe function

Indexed keywords

LEVODOPA; PERGOLIDE; ROPINIROLE; SELEGILINE;

ADULT; AGED; ARTICLE; CAMBRIDGE EXAMINATION FOR MENTAL DISORDER; CAMBRIDGE NEUROPSYCHOLOGICAL TEST AUTOMATED BATTERY; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PATTERN RECOGNITION; PRIORITY JOURNAL; PSYCHOMETRY; SUBSTITUTION THERAPY; VIENNA TEST SYSTEM; WORKING MEMORY;

ANTIPARKINSON AGENTS; COGNITION DISORDERS; DOPAMINE; DOPAMINE AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 84857051754     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03578.x     Document Type: Article

References (27)

1. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006; 5: 235-245.
2. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20years. Mov Disord 2008; 23: 837-844.
3. Muslimovic D, Post B, Speelman JD, De Haan RJ, Schmand B. Cognitive decline in Parkinson's disease: a prospective longitudinal study. J Int Neuropsychol Soc 2009; 15: 426-437.
4. Dubois B, Pillon B. Cognitive deficits in Parkinson's disease. J Neurol 1997; 244: 2-8.
5. Stoffers D, Berendse HW, Deijen JB, Wolters EC. Motor perseveration is an early sign of Parkinson's disease. Neurology 2001; 57: 2111-2113.
6. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005; 65: 1239-1245.
7. Caviness JN, Driver-Dunckley E, Connor DJ, et al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007; 22: 1272-1277.
8. Janvin CC, Larsen JP, Aarsland D, Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord 2006; 21: 1343-1349.
9. Levy G, Jacobs DM, Tang MX, et al. Memory and executive function impairment predict dementia in Parkinson's disease. Mov Disord 2002; 17: 1221-1226.
10. Williams-Gray CH, Evans JR, Goris A, et al. The distinct cognitive syndromes of Parkinson's disease: 5year follow-up of the CamPaIGNCohort. Brain 2009; 132: 2958-2969.
11. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 2006; 30: 1-23.
12. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752.
13. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986; 149: 698-709.
14. Starkstein SE, Merello M. The unified Parkinson's disease rating scale: validation study of the mentation, behavior, and mood section. Mov Disord 2007; 22: 2156-2161.
15. Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004; 19: 020-1028.
16. Hobson P, Meara J. The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test. Age Ageing 1999; 28: 39-43.
17. Visser M, Leentjens AF, Marinus J, Stiggelbout AM, van Hilten JJ. Reliability and validity of the Beck depression inventory in patients with Parkinson's disease. Mov Disord 2006; 21: 668-672.
18. Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbit P. A neural system approach to the cognitive psychology of ageing using the CANTAB battery. In: Rabbit D ed. Methodology of Frontal and Executive Function. Hove, UK: Psychology press, 2002: 215-235.
19. Robbins TW, James M, Owen AM, et al. A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. Cambridge neuropsychological test automated battery. J Int Neuropsychol Soc 1998; 4: 474-490.
20. Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW. Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 1990; 28: 1021-1034.
21. Shahakian BJ, Morris RG, Evenden JL, et al. A comparative study of visuospatial memory and learning in Alzheimer type dementia and Parkinson's disease. Brain 1988; 111: 695-718.
22. Zgaljardic DJ, Borod JC, Foldi NS, Mattis P. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn Behav Neurol 2003; 16: 193-210.
23. Curtis CE. Prefrontal and parietal contributions to spatial working memory. Neuroscience 2006; 139: 173-180.
24. Owen AM. Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry. Neuroscientist 2004; 10: 525-537.
25. Rogers RD, Andrews TC, Grasby PM, Brooks DJ, Robbins TW. Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans. J Cogn Neurosci 2000; 12: 142-162.
26. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004; 127: 550-560.
27. Owen AM, Sahakian BJ, Semple J, Polkey CE, Robbins TW. Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 1995; 33: 1-24.